Search clinical trials for: KD-025

Total 3999 results

National Center for Complementary and Integrative...

Withdrawn

Preliminary Human Trial of NPI-028

Alcoholism
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating PRA-027 Multiple Ascending Doses In Cycling And Postmenopausal Women

Uterine Leiomyomata (Fibroids)

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PRA-027 Administered to Healthy Japanese Females

Uterine Leiomyomata (Fibroids)

Japan
Wyeth is now a wholly owned subsidiary of Pfizer
Emergent Product Development Seattle LLC

Terminated

Study of TRU-015 in Subjects With Membranous Nephropathy Secondary to Systemic Lupus Erythematosus

Systemic Lupus Erythematosus

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating MYO-029 in Adult Muscular Dystrophy

Becker Muscular Dystrophy | Facioscapulohumeral Muscular Dystrophy | Limb-Girdle Muscular Dystrophy

United States
Humedix Co., Ltd.

Recruiting

Efficacy and Safety of HMM1-022 in Temporary Correction of Crow's Feet

Crows Feet

Korea, Republic of
Carisma Therapeutics Inc

Recruiting

CAR-monocytes for the Treatment of HER2 Overexpressing Solid Tumors

HER2-positive

United States
AbbVie

Recruiting

Study to Evaluate Adverse Events and Change in Disease Activity in Adult Participants With B-Cell Malignancies Receiving Oral ABBV-525 Tablets

Diffuse Large B-Cell Lymphoma | Non-Hodgkin's Lymphoma | Chronic Lymphocytic Leukemia | B Cell Malignancies

United States, Israel, Australia, France, United Kingdom, Belgium, Spain
Foresee Pharmaceuticals Co., Ltd.

Recruiting

A Dose Escalation Study of FP-045 in Patients With Fanconi Anemia

Fanconi Anemia

United States
Beijing InnoCare Pharma Tech Co., Ltd.

Completed

A Study of ICP-022 in Patients With R/R DLBCL (DLBCL)

Diffuse Large B Cell Lymphoma

China
Beijing InnoCare Pharma Tech Co., Ltd.

Completed

A Study of ICP-022 in the Treatment of Recurrent or Refractory Waldenstrom Macroglobulinemia

Waldenstrom's Macroglobulinemia Recurrent | Waldenstrom's Macroglobulinemia Refractory

China
RSP Systems A/S

Completed

A Study of a Non-invasive Glucose Measuring Device in Out-patient Settings

Diabetes Mellitus

Germany
BJ Bioscience, Inc.

Active, not recruiting

A First-in-Human, Phase 1 Dose-Escalation and Cohort Expansion Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BJ-005 in Patients With Advanced Solid Tumor or Lymphoma

Advanced Solid Tumor or Lymphoma

United States
DermBiont, Inc.
Zepeda Dermatologia

Active, not recruiting

Adaptive Design Study for Safety and Efficacy of Treatment Regimens With SM-020 in Subjects With Seborrheic Keratosis

Seborrheic Keratosis

El Salvador
RSP Systems A/S

Completed

Study of a Non-invasive Glucose Measuring Device

Diabetes Mellitus

Germany
Shanghai Kechow Pharma, Inc.

Completed

Study of HL-085 in NRAS Mutant Advanced Melanoma

Melanoma

China
Shanghai Kechow Pharma, Inc.

Completed

HL-085 in NRAS-mutated Advanced Melanoma

Melanoma

China
Palvella Therapeutics, Inc.

Active, not recruiting

VALO-2: Study Evaluating the Safety and Efficacy of PTX022 in the Treatment of Adults With Pachyonychia Congenita (VALO-2)

Pachyonychia Congenita

United States
RSP Systems A/S

Completed

Study of a Novel Non-invasive Glucose Monitoring Device

Diabetes Mellitus

Denmark
AO GENERIUM

Completed

A Multi-cohort Study of the Tolerance, Safety, and Pharmacokinetics of GNR-055 in Healthy Volunteers

Metabolic Diseases | Mucopolysaccharidosis Type II

Russian Federation
Idorsia Pharmaceuticals Ltd.

Completed

A Study to Evaluate ID-085 in People With Mild, Moderate, and Severe Kidney Disease

Renal Impairment

Germany
M.D. Anderson Cancer Center
Direct Therapeutics

Completed

Phase I Trial of Intramural Injection of DTI-015 for Recurrent Malignant Gliomas

Glioma | Brain Neoplasms

United States
National Institute of Arthritis and Musculoskeletal...

Withdrawn

A Pilot Study of XOMA 052 in Familial Cold Autoinflammatory Syndrome / Muckle-Wells Syndrome and Behcet's Disease

Behcet's Disease | Muckle Wells Syndrome | Autoinflammatory

United States
Akinion Pharmaceuticals AB

Terminated

Safety Study of AKN-028 in Patients With Acute Myelogenous Leukemia

Acute Myeloid Leukemia

Sweden, Poland, Czech Republic, United Kingdom
Astellas Pharma Inc

Completed

Study of Oral OSI-027 in Patients With Advanced Solid Tumors or Lymphoma

Any Solid Tumor or Lymphoma

United States, Belgium, United Kingdom
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study of the Safety, Tolerability, and PK of PRA-027 Administered to Women of Nonchildbearing Potential

Fibroid

United States
Takeda

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Ascending Single- and Multiple-Doses of TAK-020 in Healthy Volunteers

Healthy Volunteers

United States
The Deutsche Diabetes Forschungsgesellschaft e.V.
Algiax Pharmaceuticals GmbH

Recruiting

Effects of GABAA Receptor Modulation by AP-325 on Insulin Secretion in Patients With Type 2 Diabetes

Type2 Diabetes

Germany
Foresee Pharmaceuticals Co., Ltd.
InClin, Inc.

Not yet recruiting

Safety, Tolerability, and Pharmacokinetics, of Single and Multiple Ascending Doses of FP-020 in Healthy Adult Volunteers

Healthy

Australia
Algiax Pharmaceuticals GmbH
FGK Clinical Research GmbH

Recruiting

AP-325 in Subjects With Peripheral Post-surgical Neuropathic Pain

Peripheral Post-surgical Neuropathic Pain

Czechia, Germany, Spain, Belgium, France
Amgen

Active, not recruiting

A Multicenter Trial to Evaluate the Efficacy, Safety and Tolerability of HZN-825 in Subjects With Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis

United States, Spain, Korea, Republic of, Australia, Japan, Canada, Taiwan, Netherlands, Italy, Chile, Greece, Mexico, Germany, France, Argentina, Poland, Turkey, South Africa, United Kingdom
101 Therapeutics

Active, not recruiting

Study to Evaluate Pharmacokinetics, Safety & Tolerability of 101-PGC-005 in Healthy, Adult, Human Subjects

Virus Diseases | COVID-19 | Infectious Disease | Glucocorticoids Toxicity

India
Affibody

Completed

A Study to Investigate the Safety, Tolerability, Pharmacokinetic, and Efficacy of ABY-035/AFO2

Psoriasis

United States
Taiho Pharmaceutical Co., Ltd.

Completed

A Study of TAS-205 for Duchenne Muscular Dystrophy

Duchenne Muscular Dystrophy

Japan
Takeda

Completed

Phase 1 TAK-925 Study in Healthy Adult and Elderly Volunteers and Participants With Narcolepsy

Healthy Participants and Patients With Narcolepsy

Japan
Palvella Therapeutics, Inc.

Unknown

Phase 2/3 Study Evaluating the Safety and Efficacy of PTX-022 in Treatment of Adults With Pachyonychia Congenita

Pachyonychia Congenita

United States
Bioiberica
University of Valencia

Completed

Effects of PRJ-205 on Performance in Trained Young Subjects

Healthy

Spain
Hoffmann-La Roche

Completed

Study of Ro 205-2349 in Patients With Type 2 Diabetes Mellitus

Diabetes

United States, Panama, Mexico, Canada, Estonia, Lithuania, Bulgaria, Romania, Latvia, Puerto Rico, United Kingdom
Ain Shams Maternity Hospital

Unknown

CA-125 and Severity of Pre-Eclampsia

Pre-Eclampsia
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Effect of IMA-026 on Allergen-Induced Late Asthma Response in Mild Asthma

Asthma
Shandong University

Not yet recruiting

A Clinical Trial of the Orelabrutinib in the Management of Refractory ITP

Immune Thrombocytopenia | Bruton's Tyrosine Kinase
Seelos Therapeutics, Inc.

Terminated

STRIDES - a Clinical Research Study of an Investigational New Drug to Treat Spinocerebellar Ataxia (STRIDES)

Spinocerebellar Ataxia Type 3

United States, Spain, Korea, Republic of, Australia, United Kingdom, Brazil, Germany, Portugal
GTx

Withdrawn

Study to Assess Long-Term Safety/Tolerability of Enobosarm (GTx 024) in Stress Urinary Incontinence

Stress Urinary Incontinence

United States
RSP Systems A/S

Withdrawn

Performance and Safety Evaluation of a Novel Non-invasive Glucose Monitoring Device

Diabetes Mellitus

Denmark, Germany, Sweden, United Kingdom
GTx

Completed

GTx-024 as a Treatment for Stress Urinary Incontinence in Women

Stress Urinary Incontinence

United States
LG Chem

Completed

A Study To Evaluate The Safety, Pharmacokinetics/Pharmacodynamics (PK/PD) and Food Effect Of LC51-0255

Healthy

Korea, Republic of
Beijing InnoCare Pharma Tech Co., Ltd.

Completed

ADME Study of [14C]ICP-022 in Healthy Males

Healthy Volunteers

China
Taiho Pharmaceutical Co., Ltd.

Completed

A Phase IIa Study of TAS-205 for Duchenne Muscular Dystrophy

Duchenne Muscular Dystrophy

Japan
Millennium Pharmaceuticals, Inc.

Completed

Study of TAK-925 in Participants With Obstructive Sleep Apnea (OSA) Who Are Experiencing Excessive Daytime Sleepiness (EDS) Despite Adequate Use of Continuous Positive Airway Pressure (CPAP)

Obstructive Sleep Apnea

United States
XOMA (US) LLC

Suspended

Safety and Pharmacokinetics Study of XOMA 052 in Subjects With Active, Stable, Moderate to Severe Rheumatoid Arthritis

Rheumatoid Arthritis

United States

Search clinical trials for: KD-025

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Kingdom

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations